Search

everythinglearnresearchcommunity

for

Search:↓

Anti-TNF therapy can cause a unique type of hair loss that may get better with topical treatments without stopping the therapy.

Anti-TNF therapy can cause hair loss and skin issues.

Some drugs used to treat immune conditions may cause different types of hair loss.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Stopping the medication infliximab and starting new treatments helped a woman's hair grow back and improved her scalp condition.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Anti-TNF therapy can cause weight gain and hair loss, leading some patients to stop treatment.

Biologics show promise in treating various stubborn skin diseases, but more research and better reimbursement criteria are needed.

Stopping adalimumab and starting methotrexate with topical treatments improved the woman's scalp psoriasis and hair regrew.

Experts don't fully agree on how to diagnose certain hair growth disorders and more research is needed to understand them better.

Shrinking of oil glands in the skin is a key sign of hair loss linked to TNF inhibitor drugs and may improve if the treatment is stopped.

Scalp psoriasis can cause different types of hair loss, with some patients developing permanent hair loss, and treatment may be stopped due to skin reactions.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

Dermoscopy helps diagnose unusual skin lesions like osteonevus of Nanta and can prevent misdiagnosis of serious conditions.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

2011 dermatology discussions highlighted stem cell hair treatments, new lichen planopilaris therapies, skin side effects from cancer drugs, emerging allergens, and the link between food allergies and skin issues.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

The document concludes that lifestyle changes and medical treatments can significantly reduce symptoms of Hidradenitis Suppurativa, a chronic skin condition.

Brazilian patients with inflammatory bowel disease have a high rate of skin problems compared to healthy people.

DHT inhibition may increase spinal bone growth in ankylosing spondylitis.

Albumin and prednisone improved symptoms in a woman with Cronkhite-Canada syndrome, revealing potential genetic causes.

A girl with Crohn's disease developed hair loss due to her increased medication, a rare side effect seen in some children.

Psoriasis is linked to other autoimmune diseases and involves a specific inflammatory process.

Recombinant thrombomodulin can effectively treat severe complications in Cronkhite-Canada syndrome.

Dupilumab may cause significant hair loss, which can reverse after stopping the drug.

Acne is linked to inflammation and insulin resistance, and is associated with various syndromes that require different treatments.